SEC Form 4 · accession 0001424422-16-000026
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kin Foong Chan
Officer — EVP of R&D
Period of report
Jul 1, 2016
Accepted (ET)
Jul 6, 2016 · 6:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF1 | $0.65 | Jul 1, 2016 | A | 55,000 | A | Jul 1, 2017 | Jul 1, 2026 | Common stock | 55,000 | 55,000 | D |
Explanation of responses
- F1This option vests as to 25% of the shares subject to the option on the first anniversary date of the grant with an additional 1/36th of the remaining shares vesting on the last day of each full calendar month thereafter.